We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nkarta Inc | NASDAQ:NKTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.52 | 7.78% | 7.20 | 7.18 | 7.21 | 7.26 | 6.60 | 6.67 | 467,742 | 19:35:47 |
SVB Leerink 10th Annual Global Healthcare ConferenceFebruary 26, 2021Fireside chat presentation: 1:40 p.m. ETCowen 41st Annual Health Care ConferenceMarch 3-4, 2021No presentationBarclays Global Healthcare ConferenceMarch 11, 2021Fireside chat presentation: 10:20 a.m. ET |
Live audio webcasts of the presentations will be available on the Investors section of Nkarta’s website, www.nkartatx.com. Replays of the webcasts will be archived on the website for approximately four weeks.
About NkartaNkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, which are engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.
Nkarta Media/Investor Contact:Greg MannNkarta, Inc.gmann@nkartatx.com
1 Year Nkarta Chart |
1 Month Nkarta Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions